CanaQuest Announces Key Appointments to Team to Drive CQ-001 through Clinical Trials
11. Juni 2024 09:00 ET
|
CanaQuest Medical Corp.
Appointee, formerly with GW Pharma (subsidiary), brings extensive expertise in cannabinoid therapeutics, including the FDA-approved launch of cannabidiol (Epidiolex®) TORONTO, ON, June 11, 2024 ...